280 related articles for article (PubMed ID: 29278440)
1. A novel lateral flow immunoassay for the rapid detection of anti-Dsg3 IgG serum autoantibodies in pemphigus vulgaris.
Schmidt T; Mauracher S; Bender L; Greene B; Kurzhals J; Eming R; Dostatni R; Hertl M
Exp Dermatol; 2018 Mar; 27(3):233-237. PubMed ID: 29278440
[TBL] [Abstract][Full Text] [Related]
2. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
Atzori L; Deidda S; Aste N
G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
[TBL] [Abstract][Full Text] [Related]
3. Clues to diagnosis for unusual mucosal pemphigus demonstrating undetectable anti-desmoglein 3 serum antibodies by routine tests.
Kamiya K; Aoyama Y; Yamaguchi M; Ukida A; Mizuno-Ikeda K; Fujii K; Hamada T; Tokura Y; Iwatsuki K
J Dermatol; 2015 Jun; 42(6):572-9. PubMed ID: 25832452
[TBL] [Abstract][Full Text] [Related]
4. Validation of chemiluminescent enzyme immunoassay in detection of autoantibodies in pemphigus and pemphigoid.
Fujio Y; Kojima K; Hashiguchi M; Wakui M; Murata M; Amagai M; Yamagami J
J Dermatol Sci; 2017 Mar; 85(3):208-215. PubMed ID: 28012821
[TBL] [Abstract][Full Text] [Related]
5. [Detection of serum desmoglein antibody level using enzyme-linked immunosorbent assay (ELISA) for monitoring disease activity in patients with pemphigus vulgaris].
Zhong S; Qiu YF; Han BB; Zhao JY; Zhu XJ; Chen XX
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):414-5. PubMed ID: 21681274
[TBL] [Abstract][Full Text] [Related]
6. Using desmoglein 1 and 3 enzyme-linked immunosorbent assay as an adjunct diagnostic tool for pemphigus.
Huang CH; Chen CC; Wang CJ; Chang YT; Liu HN
J Chin Med Assoc; 2007 Feb; 70(2):65-70. PubMed ID: 17339147
[TBL] [Abstract][Full Text] [Related]
7. Coexistence of IgA antibodies to desmogleins 1 and 3 in pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus.
Mentink LF; de Jong MC; Kloosterhuis GJ; Zuiderveen J; Jonkman MF; Pas HH
Br J Dermatol; 2007 Apr; 156(4):635-41. PubMed ID: 17263817
[TBL] [Abstract][Full Text] [Related]
8. Serum and salivary IgG and IgA antibodies to desmoglein 3 in mucosal pemphigus vulgaris.
Ali S; Kelly C; Challacombe SJ; Donaldson AN; Bhogal BS; Setterfield JF
Br J Dermatol; 2016 Jul; 175(1):113-21. PubMed ID: 26799252
[TBL] [Abstract][Full Text] [Related]
9. Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal Mice.
Hofrichter M; Dworschak J; Emtenani S; Langenhan J; Weiß F; Komorowski L; Zillikens D; Stöcker W; Probst C; Schmidt E; Goletz S
Front Immunol; 2018; 9():1935. PubMed ID: 30233569
[TBL] [Abstract][Full Text] [Related]
10. Development of an enzyme-linked immunosorbent assay for detection of circulating IgG autoantibodies against canine desmoglein 3 in dogs with pemphigus.
Nishifuji K; Tamura K; Konno H; Olivry T; Amagai M; Iwasaki T
Vet Dermatol; 2009 Oct; 20(5-6):331-7. PubMed ID: 20178469
[TBL] [Abstract][Full Text] [Related]
11. Desmoglein 3-ELISA: a pemphigus vulgaris-specific diagnostic tool.
Lenz P; Amagai M; Volc-Platzer B; Stingl G; Kirnbauer R
Arch Dermatol; 1999 Feb; 135(2):143-8. PubMed ID: 10052398
[TBL] [Abstract][Full Text] [Related]
12. Keratin Retraction and Desmoglein3 Internalization Independently Contribute to Autoantibody-Induced Cell Dissociation in Pemphigus Vulgaris.
Schlögl E; Radeva MY; Vielmuth F; Schinner C; Waschke J; Spindler V
Front Immunol; 2018; 9():858. PubMed ID: 29922278
[No Abstract] [Full Text] [Related]
13. Salivary Samples for the Diagnosis of Pemphigus vulgaris Using the BIOCHIP Approach: a Pilot Study.
Russo I; Saponeri A; Michelotto A; Alaibac M
In Vivo; 2017 Jan; 31(1):97-99. PubMed ID: 28064226
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus.
Amagai M; Komai A; Hashimoto T; Shirakata Y; Hashimoto K; Yamada T; Kitajima Y; Ohya K; Iwanami H; Nishikawa T
Br J Dermatol; 1999 Feb; 140(2):351-7. PubMed ID: 10233237
[TBL] [Abstract][Full Text] [Related]
15. The use of BIOCHIP technique in diagnosis of different types of pemphigus: Vulgaris and foliaceus.
Adaszewska A; Kalinska-Bienias A; Jagielski P; Wozniak K; Kowalewski C
J Immunol Methods; 2019 May; 468():35-39. PubMed ID: 30910537
[TBL] [Abstract][Full Text] [Related]
16. A higher correlation of the antibody activities against the calcium-dependent epitopes of desmoglein 3 quantified by ethylenediaminetetraacetic acid-treated enzyme-linked immunosorbent assay with clinical disease activities of pemphigus vulgaris.
Kamiya K; Aoyama Y; Shirafuji Y; Hamada T; Morizane S; Fujii K; Iwatsuki K
J Dermatol Sci; 2013 Jun; 70(3):190-5. PubMed ID: 23602628
[TBL] [Abstract][Full Text] [Related]
17. Anti-skin specific autoantibodies detected by a new immunofluorescence multiplex biochip method in patients with autoimmune bullous diseases.
Tampoia M; Zucano A; Villalta D; Antico A; Bizzaro N
Dermatology; 2012; 225(1):37-44. PubMed ID: 22907099
[TBL] [Abstract][Full Text] [Related]
18. IgG, IgA and IgE autoantibodies against the ectodomain of desmoglein 3 in active pemphigus vulgaris.
Spaeth S; Riechers R; Borradori L; Zillikens D; Büdinger L; Hertl M
Br J Dermatol; 2001 Jun; 144(6):1183-8. PubMed ID: 11422039
[TBL] [Abstract][Full Text] [Related]
19. Controversial role of antibodies against linear epitopes of desmoglein 3 in pemphigus vulgaris, as revealed by semiquantitative living cell immunofluorescence microscopy and in-cell ELISA.
Lanza A; Perillo L; Landi C; Femiano F; Gombos F; Cirillo N
Int J Immunopathol Pharmacol; 2010; 23(4):1047-55. PubMed ID: 21244754
[TBL] [Abstract][Full Text] [Related]
20. Low pathogenicity of anti-desmoglein 3 immunoglobulin G autoantibodies contributes to the atypical clinical phenotypes in pemphigus.
Saleh MA; Hashimoto R; Kase Y; Amagai M; Yamagami J
J Dermatol; 2015 Jul; 42(7):685-9. PubMed ID: 25914046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]